Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results